CURA.TO Curaleaf Holdings, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
20:11
Sep 08
Sep 08
Curaleaf says its Aurora offer beats standalone plan
Curaleaf argues its proposal to acquire Aurora offers a 45% premium (110% excluding Aurora's cash) and that Aurora's standalone turnaround plan will not create more value. The mechanism is that Aurora's continued ATM issuances below the offer price, roughly C$5 billion in impairments and negative operating cash flow since FY21 undermine its standalone case, making the Curaleaf offer the better outcome for Aurora holders. The main stated risk is Aurora's claim that Curaleaf's leverage is a risk and that the US$5.00 cap limits upside. No explicit time horizon is given.
HIGH
21:52
Aug 11
Aug 11
Notes hostile takeover bid for Aurora Cannabis
Notes the company launched a hostile takeover bid for Aurora Cannabis.
LOW
13:01
Aug 11
Aug 11
Curaleaf announces a hostile takeover bid for Aurora at a 45% premium.
Curaleaf announces a hostile takeover bid for Aurora at a 45% premium, which the author sees as bullish for cannabis consolidation and likely to trigger more deals.
13:01
Aug 11
Aug 11
Curaleaf launches hostile bid for Aurora Cannabis
Reports Curaleaf's hostile takeover bid for Aurora Cannabis at a significant premium to recent prices.
MED
20:10
Apr 23
Apr 23
Curaleaf is a massive buying opportunity.
Curaleaf is a massive buying opportunity because rescheduling cannabis to Schedule 3 removes the punitive 280E tax, enables research, and makes it very profitable; as the largest global player, it will benefit from consolidation and institutional capital returning to the sector.
HIGH
00:25
Feb 03
Feb 03
Schedule III rescheduling removes 280E, repricing Curaleaf higher
The author holds Curaleaf as part of the same cannabis policy catalyst: Schedule III rescheduling would remove 280E tax burdens and improve operating cash flow. He expects beaten-down cannabis stocks to reprice violently once the executive branch completes the process, with rumors pointing to near-term action.
HIGH
About CURA.TO Investor Commentary
Across the available history and selected sources, Buzzberg tracks CURA.TO (Curaleaf Holdings, Inc.) across 4 sources: 3 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 6 total trade ideas tracked. Latest voices: u/CuraleafSupportTeam, stocks_stones, Boris Jordan.